Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.
- Published In:
- Nature medicine, 30(10), 2849-2856 (2024)
- Authors:
- Mann, Johannes F E(7), Rossing, Peter(6), Bakris, George(2), Belmar, Nicolas, Bosch-Traberg, Heidrun, Busch, Robert, Charytan, David M, Hadjadj, Samy, Gillard, Pieter, Górriz, José Luis, Idorn, Thomas, Ji, Linong, Mahaffey, Kenneth W, Perkovic, Vlado, Rasmussen, Søren, Schmieder, Roland E, Pratley, Richard E, Tuttle, Katherine R
- Database ID:
- RPEP-08810
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08810APA
Mann, Johannes F E; Rossing, Peter; Bakris, George; Belmar, Nicolas; Bosch-Traberg, Heidrun; Busch, Robert; Charytan, David M; Hadjadj, Samy; Gillard, Pieter; Górriz, José Luis; Idorn, Thomas; Ji, Linong; Mahaffey, Kenneth W; Perkovic, Vlado; Rasmussen, Søren; Schmieder, Roland E; Pratley, Richard E; Tuttle, Katherine R. (2024). Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.. Nature medicine, 30(10), 2849-2856. https://doi.org/10.1038/s41591-024-03133-0
MLA
Mann, Johannes F E, et al. "Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.." Nature medicine, 2024. https://doi.org/10.1038/s41591-024-03133-0
RethinkPeptides
RethinkPeptides Research Database. "Effects of semaglutide with and without concomitant SGLT2 in..." RPEP-08810. Retrieved from https://rethinkpeptides.com/research/mann-2024-effects-of-semaglutide-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.